Segall Bryant & Hamill LLC Sells 109,297 Shares of Ingevity Corporation $NGVT

Segall Bryant & Hamill LLC trimmed its position in Ingevity Corporation (NYSE:NGVT) by 9.0% during the first quarter, HoldingsChannel.com reports. The firm owned 1,109,048 shares of the company’s stock after selling 109,297 shares during the quarter. Ingevity accounts for approximately 1.0% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 8th biggest holding. Segall Bryant & Hamill LLC’s holdings in Ingevity were worth $78,997,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of NGVT. Assetmark Inc. grew its holdings in shares of Ingevity by 9.6% during the first quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock worth $113,000 after buying an additional 139 shares in the last quarter. Advisory Services Network LLC lifted its stake in Ingevity by 4.4% in the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock valued at $383,000 after acquiring an additional 293 shares in the last quarter. Amundi boosted its position in Ingevity by 4.8% during the 3rd quarter. Amundi now owns 6,626 shares of the company’s stock worth $364,000 after acquiring an additional 302 shares during the last quarter. Isthmus Partners LLC boosted its position in Ingevity by 0.5% during the 4th quarter. Isthmus Partners LLC now owns 72,245 shares of the company’s stock worth $4,275,000 after acquiring an additional 375 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares during the last quarter. 91.59% of the stock is owned by institutional investors and hedge funds.

Ingevity Stock Up 4.2%

Ingevity stock opened at $73.16 on Friday. The firm has a market capitalization of $2.54 billion, a PE ratio of 49.77 and a beta of 1.16. The company’s 50-day moving average is $71.76 and its 200-day moving average is $70.97. Ingevity Corporation has a fifty-two week low of $39.74 and a fifty-two week high of $79.29. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 0.92.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Sell-side analysts anticipate that Ingevity Corporation will post 5.05 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on NGVT. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $80.00.

Insiders Place Their Bets

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the sale, the senior vice president owned 7,202 shares in the company, valued at $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.88% of the stock is currently owned by company insiders.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.